Lv3
257 积分 2021-08-18 加入
On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
8小时前
待确认
On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
8小时前
已完结
Association of change in healthy lifestyle in early adulthood with steatotic liver disease risk in midlife
9小时前
已完结
Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
1个月前
已完结
Development and initial validation of the nonalcoholic fatty liver disease self-management questionnaire
1个月前
已完结
Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors
1个月前
已关闭
Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors
1个月前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
2个月前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
2个月前
已完结
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study
2个月前
已完结
皖公网安备34019202002308
